| Item |
Tumor group (n = 43) |
Non-tumor group (n = 18) |
||||||||||
| Anemia group (n = 33) |
Non-anemia group (n = 10) |
Anemia group (n = 9) |
Non-anemia group (n = 9) |
|||||||||
| Before treatment |
After treatment |
t |
Before treatment |
After treatment |
t |
Before treatment |
After treatment |
t |
Before treatment |
After treatment |
t |
|
| Hb (g/L)
|
85.45 ± 18.33 |
91.18 ± 15.91 |
1.9711* |
122.80 ± 7.08 |
118.40 ± 11.47 |
1.0320 |
81.33 ± 39.04 |
84.44 ± 37.27 |
0.1729 |
123.78 ± 47.34 |
118.33 ± 47.17 |
0.2446 |
| BMP6 (mg/ml)
|
172.60 ± 99.80 |
167.76 ± 94.00 |
0.1838 |
155.74 ± 47.10 |
151.42 ± 37.48 |
0.2270 |
177.74 ± 77.69 |
171.96 ± 88.19 |
0.1312 |
117.69 ± 59.17 |
119.69 ± 59.17 |
0.0480 |
| Hepcidin (mg/L) |
1.09 ± 0.41 |
0.73 ± 0.45 |
3.3941# |
1.07 ± 0.32 |
1.07 ± 0.33 |
0.0010 |
0.89 ± 0.52 |
0.80 ± 0.51 |
0.3721 |
79 ± 0.41 |
0.84 ± 0.48 |
0.2240 |
| IL-6 (mg/ml) |
50.76 ± 42.10 |
30.33 ± 28.39 |
2.3597* |
37.57 ± 45.37 |
25.29 ± 18.92 |
1.4334 |
19.01 ± 15.72 |
19.72 ± 812.4 |
0.0809 |
14.41 ± 12.60 |
39.64 ± 7.45 |
1.6015 |